Dr Nuala Murphy was appointed to the board of Cerba HealthCare in 2023, in addition to assuming the chair of the ESG committee and executive chair of Cerba Research. 

With a background in drug development, Nuala is a strategic advisor to private equity, having held leadership & board roles in the pharmaceutical sector, most recently as President of Drug development and Commercialization at ICON Plc. 

Nuala graduated from Trinity College Dublin, was awarded a PhD from the School of Medicine at the University of Leeds, a post-doctorate in neuroscience from the Collège de France, Paris, a diploma in ESG from the Corporate Governance Institute and was certified in corporate governance at INSEAD.

Benoît joined the Cerba HealthCare Board in 2023.

Benoît Ribadeau-Dumas spent 15 years in senior management positions in the industry sector (Thales, CGG, Zodiac Aerospace), before becoming Chief of Staff to French Prime Minister Edouard Philippe from 2017 to 2020.

Benoît is now Managing Director at Exor and a member of various boards, including Stellantis, Iveco, Institut Mérieux and Galileo Global Education.
 

He gradutated from Polytechnique and Ecole Nationale d’Administration.

Stefano joined Cerba HealthCare in 2016. 

He has over 10 years of experience as CEO of Delta Medica, network of medical centres, polyclinics and laboratories in Italy. 

Stefano, a qualified attorney with a Doctor of Law degree from Università degli Studi di Milano, has leveraged this experience to further expand Cerba HealthCare Italia in order to provide greater value for patients and physicians throughout the country.